DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Schiff Nutrition International, Inc. (“Schiff”) (NYSE: SHF) to Bayer HealthCare, LLC for shareholders. Under the proposed sale, Schiff shareholders will only receive $34 in cash for each share of Schiff common stock owned in a deal valued at approximately $1.2 billion.
If you are an affected investor, and you want to learn more about the lawsuit or join the action, contact Patrick Powers at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at email@example.com, or Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you.
The Schiff sale investigation centers on whether Schiff shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues Schiff stock, and whether Schiff’s board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal. Shareholder rights attorney Willie Briscoe stated that “because Schiff has recently projected a substantial increase in net sales, we believe that the transaction may undervalue Schiff stock. Our lawsuit will seek to obtain the highest share price for all shareholders.”
The Briscoe Law Firm, PLLC is a full service business litigation and shareholder rights advocacy firm with more than 20 years of experience in complex litigation and transactional matters.
Powers Taylor, LLP is a boutique litigation law firm that handles a variety of complex business litigation matters, including claims of investor and stockholder fraud, shareholder oppression, shareholder derivative suits, and security class actions.
Source: Powers Taylor, LLP